St. Louis biotech startup acquires German firm, snags private equity investment

St. Louis Business Journal

Apr 29, 2019

Canopy Biosciences, a St. Louis-based biotech startup and provider of gene editing and gene expression products and services, has acquired a German firm and closed an investment fr…